Social/economic costs and health-related quality of life in patients with rare diseases in Europe.
about
Health Economic Data in Reimbursement of New Medical Technologies: Importance of the Socio-Economic Burden as a Decision-Making CriterionMulti-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.Cost-of-Illness in Rare Diseases.
P2860
Social/economic costs and health-related quality of life in patients with rare diseases in Europe.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Social/economic costs and heal ...... with rare diseases in Europe.
@en
Social/economic costs and heal ...... with rare diseases in Europe.
@nl
type
label
Social/economic costs and heal ...... with rare diseases in Europe.
@en
Social/economic costs and heal ...... with rare diseases in Europe.
@nl
prefLabel
Social/economic costs and heal ...... with rare diseases in Europe.
@en
Social/economic costs and heal ...... with rare diseases in Europe.
@nl
P2860
P1476
Social/economic costs and heal ...... s with rare diseases in Europe
@en
P2093
Julio López-Bastida
Pedro Serrano-Aguilar
P2860
P2888
P356
10.1007/S10198-016-0780-7
P478
17 Suppl 1
P577
2016-03-29T00:00:00Z